PCRX Deferred Revenue
Pacira Biosciences Inc · Deferred Revenue
PCRX Deferred Revenue
Latest reported$0.00period ending
PCRX Quarterly Deferred Revenue ($2.35M → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
PCRX deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 61,140,000 | |
| 51,985,000 | |
| -5,583,000 | |
| 0 | |
| 40,359,000 | |
| 38,434,000 | |
| 33,017,000 | |
| 102,000 | |
| 0 | |
| 0 | |
| 520,000 | |
| 595,000 | |
| 822,000 | |
| 1,048,000 | |
| 1,275,000 | |
| 1,426,000 | |
| 1,426,000 | |
| 1,426,000 | |
| 1,426,000 | |
| 1,426,000 | |
| 1,426,000 | |
| 1,426,000 | |
| 1,008,000 | |
| 1,008,000 | |
| 972,000 | |
| 972,000 | |
| 972,000 | |
| 972,000 | |
| 1,166,000 | |
| 4,353,000 | |
| 7,231,000 | |
| 13,054,000 | |
| 2,354,000 | |
| 2,458,000 | |
| 2,550,000 | |
| 2,267,000 | |
| 2,162,000 | |
| 2,184,000 | |
| 2,346,000 |